Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor
The FASEB Journal · 30.11.2024 · 38 (22)
DOI: 10.1096/fj.202401330r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 16.11.2024. Verfasst von Samantha Y Hayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: ErbB Receptors, Adaptor Proteins, Signal Transducing, Tumor Suppressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Veterans Affairs (VA), HHS | National Institutes of Health (NIH), NIGMS NIH HHS.
Abstract (Originalsprache)
Mitogen‐inducible gene 6 (Mig6) is a cellular inhibitor of epidermal growth factor receptor (EGFR) that binds directly to the EGFR kinase domain and interferes with signaling. Reduced Mig6 expression is correlated with increased EGFR activity in multiple cancer models. Here, we investigated whether disease‐associated point mutations could reduce the inhibitory potency of Mig6. We show that several cancer‐associated mutations, and a mutation derived from Alzheimer's Disease patients, diminish the ability of Mig6 to bind and inhibit EGFR in vitro. In mammalian cells, the mutations decreased the Mig6‐induced suppression of basal and EGF‐stimulated autophosphorylation, MAP kinase phosphorylation, and cell migration. To probe the mechanisms by which the mutations could lead to reduced Mig6 inhibition, we constructed atomic‐level computational models of Mig6 complexed with the EGFR catalytic domain, and performed molecular dynamics simulations for wild‐type and mutant complexes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, Stony Brook University, Stony Brook, New York, USA.
- Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA.
- Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, New York, USA.
- Department of Veterans Affairs Medical Center, Northport, New York, USA.
ORCID-Profile: Samantha Y Hayashi, Steven Pak, Antonio Torlentino, Robert C Rizzo, W Todd Miller
Förderung
- U.S. Department of Veterans Affairs (VA)
- HHS | National Institutes of Health (NIH)
- NIGMS NIH HHS
- BLRD VA
- National Institutes of Health
Zitieren
APA
Hayashi, S. Y., Pak, S., Torlentino, A., Rizzo, R. C., & Miller, W. T. (2024). Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor. The FASEB Journal, 38(22). https://doi.org/10.1096/fj.202401330r
Vancouver
Hayashi SY, Pak S, Torlentino A, Rizzo RC, Miller WT. Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor. The FASEB Journal. 2024;38(22). doi:10.1096/fj.202401330r
BibTeX
@article{Hayashi2024,
author = {Hayashi, Samantha Y and Pak, Steven and Torlentino, Antonio and Rizzo, Robert C and Miller, W Todd},
title = {Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {22},
doi = {10.1096/fj.202401330r}
}
EUVIMED